
ASCO '23 Entrees
OncoPharm
00:00
How to Survive in Multimyloma
So those are the entrees from ASCO 2023 which is now 2 weeks old and I do apologize for not having all of that ready last week but there was just so much to go over. There's a drastic difference in progression for your survival here but quite a bit of questions to remain about will that translate to overall survival in Multimyloma. A future guest on this podcast say is like the type 2 diabetes of oncology treatment is very individualized it can be a chronic disease in many patients and not everyone needs to be put on 5-drug regimen at the get-go.
Transcript
Play full episode